Chen‐Chung Liu

National Taiwan University — Taiwan

Medicine · Health Sciences

28h-index3.2kcitations204works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(78), Mental Health and Psychiatry(19), Functional Brain Connectivity Studies(17), Bipolar Disorder and Treatment(16), Mental Health Treatment and Access(12)

Publications204 total

Self-Supervised Guided Modality Disentangled Representation Learning for Multimodal Sentiment Analysis and Schizophrenia Assessment
IEEE Journal of Biomedical and Health Informatics·2025
Temporal imprecision and its dynamics in schizophrenia
Translational Psychiatry·2025· 3 citedOpen Access
Increased intra-subject variability in reward behavior relates to symptom severity in schizophrenia
Schizophrenia·2025Open Access
180. CORRELATION OF MOOD SYMPTOMS AND THE SEASONAL VARIATION OF VITAMIN D LEVELS IN TAIWANESE MOOD DISORDER PATIENTS AND HEALTHY INDIVIDUALS: A COMPARATIVE COHORT STUDY
The International Journal of Neuropsychopharmacology·2025Open Access
90. SUCCESSFUL ANTIPSYCHOTIC DOSE TAPERING LEADING TO BETTER COGNITION IN PATIENTS WITH REMITTED PSYCHOSIS: A 2-YEAR PROSPECTIVE RANDOMIZED-CONTROLLED TRIAL
The International Journal of Neuropsychopharmacology·2025Open Access
Assessing the Validity of Claims-Based Diagnostic Codes for Psychotic and Affective Disorders and the Influence of the Coding Transition from the ICD-9 to the ICD-10 in Taiwan’s National Health Insurance Research Database
Clinical Epidemiology·2025· 8 citedOpen Access
Analyzing Generative AI and Machine Learning in Auto-Assessing Schizophrenia’s Negative Symptoms
Schizophrenia Bulletin·2025· 6 cited
Truth or myth of minimum effective dose for patients with remitted psychosis: Implications from a guided dose reduction trial
Asian Journal of Psychiatry·2025
MINIMUM EFFECTIVE DOSE OF ARIPIPRAZOLE DURING MAINTENANCE FOR PATIENTS IN REMITTED STATE OF PSYCHOSIS GUIDED BY AN EXPONENTIAL TAPERING METHOD: VERIFICATION BY PLASMA DRUG CONCENTRATION
The International Journal of Neuropsychopharmacology·2025Open Access
Identification of Hub Genes Involved in Early-onset Schizophrenia: From Genetic Susceptibility to Predicted Regulated Gene Expression
2025Open Access
Successful antipsychotic dose tapering leading to better cognition in patients with remitted psychosis: Results of Guided Antipsychotic Reduction to Reach Minimum Effective Dose (GARMED) trial
Psychological Medicine·2025Open Access
T75. ASSOCIATIONS BETWEEN POLYGENIC RISK SCORE FOR SCHIZOPHRENIA AND SCHIZOTYPAL TRAITS IN THE MULTIPLEX FAMILIES OF PATIENTS WITH SCHIZOPHRENIA
European Neuropsychopharmacology·2024
30. IDENTIFICATION OF HUB GENES INVOLVED IN EARLY-ONSET SCHIZOPHRENIA USING GENETICALLY PREDICTED REGULATED GENE-EXPRESSION RISK SCORE FOR SCHIZOPHRENIA
European Neuropsychopharmacology·2024
Verification of successful maintenance by serum drug level during a guided antipsychotic reduction to reach minimum effective dose (GARMED) trial
Psychological Medicine·2024· 4 citedOpen Access
The myth of minimum effective dose in antipsychotic treatment for patients with remitted psychosis
European Neuropsychopharmacology·2024· 1 cited
In-Hospital Use of Long-Acting Injectable Antipsychotics and Readmission Risk in Patients With First-Admission Schizophrenia in Taiwan
JAMA Network Open·2024· 4 citedOpen Access
Patients with first-episode psychosis in northern Taiwan: neurocognitive performance and niacin response profile in comparison with schizophrenia patients of different familial loadings and relationship with clinical features
BMC Psychiatry·2024· 2 citedOpen Access
Rash at Birth in a Preterm Neonate
NeoReviews·2023
Work performance and its clinical correlates in patients with chronic mental illness: The Chinese version of Vocational Cognitive Rating Scale and the work behavior inventory.
Psychiatric Rehabilitation Journal·2023
Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohort
Psychological Medicine·2023· 29 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Hai‐Gwo Hwu(30), Chih‐Min Liu(27), Ming H. Hsieh(25), Tzung‐Jeng Hwang(21), Yi‐Ling Chien(18), Wei J. Chen(11), Wen‐Yih Isaac Tseng(7), Yi‐Ting Lin(7), Stephen V. Faraone(6), Ming T. Tsuang(6), Yung‐Chin Hsu(4), Cathy S.J. Fann(4), Fu-Chuang Chen(3), Shyr-Shen Yu(3), Jia‐Chi Shan(3), Yu‐Chun Lo(3), Chien-Ching Chang(3), Yen‐Nan Chiu(3), Mau‐Sun Hua(3), Po‐Hsiu Kuo(3)